PCN3 RITUXIMAB-BASED REGIMEN AS FRONTLINE THERAPY IN...

Value in Health 2019 / 11 Vol. 22

PCN3 RITUXIMAB-BASED REGIMEN AS FRONTLINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A REAL-WORLD NATIONWIDE COHORT STUDY

Ko, B.S., Huang, H.H., Wang, C.Y., Chen, H.M., Hsiao, F.Y.S.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.200
Date:
November, 2019
File:
PDF, 387 KB
2019
Conversion to is in progress
Conversion to is failed